Innovating Works
SMiPAX4: Signalling of Minor Pocket Agonists at CXCR4 Ermium Therapeutics participó en un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 The following project, SMiPAX4, conducted in the academic group of Jean-Philippe Herbeuval (Univeristy of Paris, France), is at the cross se...
2022-06-09 - 2025-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.